Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 26:10:1443.
doi: 10.3389/fonc.2020.01443. eCollection 2020.

Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review

Affiliations

Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review

Rui Huang et al. Front Oncol. .

Abstract

Conventional treatments for brain tumors relying on surgery, radiation, and systemic chemotherapy are often associated with high recurrence and poor prognosis. In recent decades, intra-arterial administration of anti-cancer drugs has been considered a suitable alternative drug delivery route to intravenous and oral administration. Intra-arterial administration is believed to offer increasing drug responses by primary and metastatic brain tumors, and to be associated with better median overall survival. By directly injecting therapeutic agents into carotid or vertebral artery, intra-arterial administration rapidly increases intra-tumoral drug concentration but lowers systemic exposure. However, unexpected vascular or neural toxicity has questioned the therapeutic safety of intra-arterial drug administration and limits its widespread clinical application. Therefore, improving targeting and accuracy of intra-arterial administration has become a major research focus. This systematic review categorizes strategies for optimizing intra-arterial administration into five categories: (1) transient blood-brain barrier (BBB)/blood-tumor barrier (BTB) disruption, (2) regional cerebral hypoperfusion for peritumoral hemodynamic changes, (3) superselective endovascular intervention, (4) high-resolution imaging techniques, and (5) others such as cell and gene therapy. We summarize and discuss both preclinical and clinical research, focusing on advantages and disadvantages of different treatment strategies for a variety of cerebral tumor types.

Keywords: blood–brain barrier; brain tumor; chemotherapy; imaging; intra-arterial; nanoparticles; superselective cerebral infusion; targeted therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Methodological approach. (A) PRISMA flow diagram. (B) Pie chart of the total number of publications between 1981 and 2020. (C) Temporal trend graph of the numbers of publications for different strategies. Since 1981, the numbers of articles on BBB/BTB disruption published in consecutive decades are 16, 42, 22, and 14, respectively. The numbers of articles on SIACI published in consecutive decades are 12, 9, 4, and 14, respectively. The numbers of articles on imaging published in consecutive decades are 8, 9, 2, and 14, respectively. The numbers of articles on TCH published in consecutive decades are 4, 8, 2, and 10, respectively. The numbers of articles on other strategies published in consecutive decades are 15, 16, 12, and 3, respectively.
Figure 2
Figure 2
Schematic diagram of strategies for improving intra-arterial administration.

References

    1. de Robles P, Fiest KM, Frolkis AD, Pringsheim T, Atta C, st. Germaine-Smith C, et al. . The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol. (2015) 17:776–83. 10.1093/neuonc/nou283 - DOI - PMC - PubMed
    1. Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. (2018) 20:iv1–86. 10.1093/neuonc/noy131 - DOI - PMC - PubMed
    1. Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin North Am. (2011) 22:1–6. 10.1016/j.nec.2010.08.007 - DOI - PubMed
    1. Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, et al. . Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. (2017) 19:1511–21. 10.1093/neuonc/nox077 - DOI - PMC - PubMed
    1. Miranda-Filho A, Pineros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol. (2017) 19:270–80. 10.1093/neuonc/now166 - DOI - PMC - PubMed

Publication types

LinkOut - more resources